Health

New FDA investigation into semaglutide drugs like Ozempic finds possible suicide risk signal, raising questions about GLP-1 safety monitoring.

FDA greenlights Eli Lilly's donanemab for early Alzheimer's, but safety risks and limited efficacy stir debate among experts.

Genetic sequencing reveals H5N1 mutation in a US patient, increasing risk of human-to-human transmission. Experts urge vigilance.

CRISPR sickle cell approval is historic, but the FDA's black-box warning over off-target edits raises safety questions.

FDA advisory panel voted against recommending LSD-assisted therapy for generalized anxiety disorder, citing insufficient efficacy data and safety concerns.

FDA warns CAR-T therapy may cause secondary cancers. New data reveals hidden risk that changes the game for oncology.

The first US case of H5N1 pig infection has been confirmed, sparking urgent CDC investigation into potential pandemic threat.

Nebraska dairy herd tests positive for H5N1, marking spread to a new state. Experts warn of escalating risk to livestock and humans.

Nebraska confirms H5N1 in a dairy herd, the 10th state affected. The outbreak raises new questions about milk safety and viral evolution.

FDA advisory committee voted against updating COVID-19 boosters for fall 2025, citing shifting virus strains and limited data.

FDA approves suzetrigine, a first-in-class non-opioid analgesic. The new drug could fundamentally change how we treat acute pain.

FDA advisory committee voted overwhelmingly against approving MDMA-assisted therapy for PTSD, citing data integrity concerns and ethical lapses.